C8 Phases: SP-C8-PK
At DAISOGEL, we recognized the need for a premier silica gel that resolves complex impurities of modern recombinant peptide therapeutics such as insulin in a sustainable, cost-effective manner.
A silica gel robust enough to withstand the rigors of alkaline CIP. A silica gel whose mechanical strength would preclude the generation of fines and hence sustain consistent operating pressures during large-scale purification in DAC columns. And a silica gel whose loading capability simply outperforms other similar medias on the market, providing the best economics for large scale peptide purification.
Premium C8 for Recombinant Peptides + Insulin
Recombinant Peptides / Insulin
The C8-PK Series has been developed based on our holistic design concept of chemical stability, mechanical strength, and high performance to provide you with the ultimate in sustainable purity. Its 11% carbon loading strikes the right balance that is ideal for the purification of fibrillating peptides.
Enhanced alkaline durability to withstand 0.1 M NaOH and high mechanical strength to provide longest lifetime when packed in DAC columns.
Superior resolution, even for self-aggregating or fibrillating peptides.
Exceptionally high surface area of 320 m2/g to provide extremely high loadability with a lower upfront cost than competing 13 μm C8 silica gels.
Ordering Information (Bonded Phase C8)
|Product Name||Pore Size (Å)||Particle Size (µm)||Pore Volume (mL/g)||Surface Area (m2/g)||% of Carbon|
Did you know?
The C8-PK Series resolution for an insulin separation demonstrated a 22.5% higher Rs than the competitor.
Other DAISOGEL Products in PK Series